Stock 2157 LEPU BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Lepu Biopharma Co., Ltd.

Equities

2157

CNE100004SM4

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
5.04 HKD +7.23% Intraday chart for Lepu Biopharma Co., Ltd. +16.94% +19.71%
Apr. 12 Keymed Biosciences Advances Solid Tumors Drug With First Patient Study MT
Mar. 27 Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

LePU Biopharma Co Ltd is a China-based biopharmaceutical company focused on tumor treatment. The Company mainly develops product lines of tumor candidate drugs, including antibody drug conjugate (ADC), oncolytic virus drug products and immunotherapy at clinical and pre-clinical stages. The Company’s major pipeline assets consist of MRG003, MRG002, HX008 and LP002, and three key clinical-stage drug candidates. The Company's products are sold at home and abroad.

Number of employees: 429

Sales per Business

HKD in Million2022Weight2023Weight Delta
Drugs for Cancer Targeted Therapy and Immunotherapy
100.0 %
18 100.0 % 249 100.0 % +1,275.13%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
18 100.0 % 249 100.0 % +1,275.13%

Managers

Managers TitleAgeSince
Ziye Sui CEO
 Chief Executive Officer - 20-04-21
Yun Yi Li DFI
 Director of Finance/CFO 44 20-12-09
Min MIn Qin CTO
 Chief Tech/Sci/R&D Officer 66 20-12-09
Maggie Geman Li PRN
 Corporate Officer/Principal 58 20-12-09
Hu Li PRN
 Corporate Officer/Principal 59 20-12-09
Lei Fang PRN
 Corporate Officer/Principal 41 20-12-09
Siu Kuen Lai SEC
 Corporate Secretary 48 21-01-27

Members of the board

Members of the board TitleAgeSince
Feng Mao Hua BRD
 Director/Board Member 56 21-11-30
Zhong Jie Pu FOU
 Founder 61 18-01-18
Yang Xu BRD
 Director/Board Member 57 20-12-09
Ming Yang BRD
 Director/Board Member 58 20-12-09
Ziye Sui CEO
 Chief Executive Officer - 20-04-21
Jue Pu BRD
 Director/Board Member 34 20-04-21
De Min Zhou BRD
 Director/Board Member 58 20-12-09
Jiwei Wang BRD
 Director/Board Member 37 20-12-09
Hongbing Yang BRD
 Director/Board Member 55 20-04-21
Hai Feng Yang BRD
 Director/Board Member 47 20-12-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 54,268,364 0 0 32.83 %
Stock B 1 1,605,176,474 544,797,708 ( 33.94 %) 0

Shareholders

NameEquities%Valuation
Zhong Jie Pu
26.99 %
433,239,436 26.99 % 177 M $
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
14.04 %
225,352,113 14.04 % 92 M $
Chao Hong Hu
8.495 %
136,355,106 8.495 % 56 M $
Rong Yu Su
5.873 %
94,274,000 5.873 % 38 M $
Jue Pu
5.607 %
90,000,000 5.607 % 37 M $
Suzhou Private Capital Investment Holdings Co. Ltd.
2.948 %
47,314,776 2.948 % 19 M $
King Star Med LP (Cayman Islands)
1.319 %
21,178,000 1.319 % 9 M $
Xiang Hong Lin
1.302 %
20,900,000 1.302 % 9 M $
Shanghai Healthcare Capital Investment Fund Co. Ltd.
0.6829 %
10,962,335 0.6829 % 4 M $
China Asset Management Co., Ltd.
0.0831 %
1,334,000 0.0831 % 543 725 $
NameEquities%Valuation
Suzhou Private Capital Investment Holdings Co. Ltd.
90.84 %
49,295,775 90.84 % 20 M $
Shanghai Healthcare Capital Investment Fund Co. Ltd.
6.733 %
3,654,111 6.733 % 1 M $

Company contact information

Lepu Biopharma Co., Ltd.

2nd Floor, Building 41 Lane 518, Xinzhuan Road

201612, Shanghai

+

http://www.lepubiopharma.com
address Lepu Biopharma Co., Ltd.(2157)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Ratings for Lepu Biopharma Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.665 CNY
Average target price
3.403 CNY
Spread / Average Target
-27.06%
Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
LEPU BIOPHARMA CO., LTD. Stock Lepu Biopharma Co., Ltd.
+19.71% 1.07B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2157 Stock
  4. Company Lepu Biopharma Co., Ltd.